|
POP-UP: a Single-arm, Two-cohort Study: Trimodal Prehab for Upper GI and Pancreatic Cancer
RECRUITINGN/ASponsored by GERCOR - Multidisciplinary Oncology Cooperative Group
Actively Recruiting
PhaseN/A
SponsorGERCOR - Multidisciplinary Oncology Cooperative Group
Started2024-06-24
Est. completion2027-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06275737
Summary
This is a multicenter, two-cohort, open-label, single-arm feasibility study. The primary objective is to assess the feasibility of the 8-week trimodal prehabilitation program alongside perioperative triplet chemotherapy in eligible patients with localized pancreatic ductal adenocarcinoma (PDAC) or oesogastric cancer (OGC) .
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Signed and dated patient informed consent form (ICF) and willingness to comply with all study procedures and availability for the study duration, * Histologically or cytologically localized PDAC or OGC validated by the multidisciplinary team, * Indication to a preoperative treatment withtriplet chemotherapy for ≥ 4 cycles (8 weeks), Note: Patient treated for PDAC, first cycle without oxaliplatin is authorized. * Age \> 18 years; If aged ≥ 75 years: G8 score must be ≥ 14 and if \< 14 validation of oncogeriatric specialist, * Eastern Cooperative Oncology Group performance status (ECOG PS) of 0-1 at inclusion visit (first prehabilitation hospital-day), * No prior treatment for PDAC or OGC before screening visit, * At least one measurable or evaluable lesion as assessed by Computerized Tomography scan or Magnetic resonance imaging according to RECIST 1.1 and feasibility of repeated radiological assessments on baseline imaging before starting chemotherapy, * Adequate hematologic and end-organ function allowing the triple combination chemotherapy protocol, * Registration in a national health care system (PUMa - Protection Universelle Maladie included). Exclusion Criteria: * Evidence of metastatic disease at imaging (validated in multidisciplinary team evaluation), * Histology of other than adenocarcinoma, * Any medical (including cardiovascular, respiratory, psychiatric, musculoskeletal, or neurological) condition contra-indicating exercise practice, * Patients with medical contraindication to surgery due to general condition or comorbidities * Pregnancy or breast-feeding, * Patient under a legal protection regime (guardianship, curatorship, judicial safeguard) or administrative decision or incapable of giving his/her consent,
Conditions3
CancerEsophageal CancerPancreatic Ductal Adenocarcinoma
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorGERCOR - Multidisciplinary Oncology Cooperative Group
Started2024-06-24
Est. completion2027-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06275737